166 related articles for article (PubMed ID: 35156575)
21. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
Alaimo S; Pulvirenti A
Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
[TBL] [Abstract][Full Text] [Related]
22. Repurposing Drugs: An Empowering Approach to Drug Discovery and Development.
Kumar S; Roy V
Drug Res (Stuttg); 2023 Nov; 73(9):481-490. PubMed ID: 37478892
[TBL] [Abstract][Full Text] [Related]
23. Drug repurposing with network reinforcement.
Nam Y; Kim M; Chang HS; Shin H
BMC Bioinformatics; 2019 Jul; 20(Suppl 13):383. PubMed ID: 31337333
[TBL] [Abstract][Full Text] [Related]
24. Considerations and challenges for sex-aware drug repurposing.
Fisher JL; Jones EF; Flanary VL; Williams AS; Ramsey EJ; Lasseigne BN
Biol Sex Differ; 2022 Mar; 13(1):13. PubMed ID: 35337371
[TBL] [Abstract][Full Text] [Related]
25. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
26. Adera2.0: A Drug Repurposing Workflow for Neuroimmunological Investigations Using Neural Networks.
Lazarczyk M; Duda K; Mickael ME; Ak O; Paszkiewicz J; Kowalczyk A; Horbańczuk JO; Sacharczuk M
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234990
[TBL] [Abstract][Full Text] [Related]
27. Integrating Biological Networks for Drug Target Prediction and Prioritization.
Ji X; Freudenberg JM; Agarwal P
Methods Mol Biol; 2019; 1903():203-218. PubMed ID: 30547444
[TBL] [Abstract][Full Text] [Related]
28. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.
Nowak-Sliwinska P; Scapozza L; Ruiz i Altaba A
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):434-454. PubMed ID: 31034926
[TBL] [Abstract][Full Text] [Related]
29. Computational drug repositioning using meta-path-based semantic network analysis.
Tian Z; Teng Z; Cheng S; Guo M
BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
[TBL] [Abstract][Full Text] [Related]
30. Drug Repurposing by Simulating Flow Through Protein-Protein Interaction Networks.
Manczinger M; Bodnár VÁ; Papp BT; Bolla SB; Szabó K; Balázs B; Csányi E; Szél E; Erős G; Kemény L
Clin Pharmacol Ther; 2018 Mar; 103(3):511-520. PubMed ID: 28643328
[TBL] [Abstract][Full Text] [Related]
31. A genome-wide positioning systems network algorithm for in silico drug repurposing.
Cheng F; Lu W; Liu C; Fang J; Hou Y; Handy DE; Wang R; Zhao Y; Yang Y; Huang J; Hill DE; Vidal M; Eng C; Loscalzo J
Nat Commun; 2019 Aug; 10(1):3476. PubMed ID: 31375661
[TBL] [Abstract][Full Text] [Related]
32. Overcoming Sparseness of Biomedical Networks to Identify Drug Repositioning Candidates.
Poleksic A
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(4):2377-2384. PubMed ID: 33591920
[TBL] [Abstract][Full Text] [Related]
33. Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing.
Martinez-Hernandez JE; Hammoud Z; de Sousa AM; Kramer F; Monte-Neto RLD; Maracaja-Coutinho V; Martin AJM
Microbiol Spectr; 2021 Oct; 9(2):e0101821. PubMed ID: 34668739
[No Abstract] [Full Text] [Related]
34. A Drug Repurposing Method Based on Drug-Drug Interaction Networks and Using Energy Model Layouts.
Udrescu M; Udrescu L
Methods Mol Biol; 2019; 1903():185-201. PubMed ID: 30547443
[TBL] [Abstract][Full Text] [Related]
35. Design of a tripartite network for the prediction of drug targets.
Kunimoto R; Bajorath J
J Comput Aided Mol Des; 2018 Feb; 32(2):321-330. PubMed ID: 29340865
[TBL] [Abstract][Full Text] [Related]
36. A Drug Repurposing and Protein-Protein Interaction Network Study of Ribosomopathies Using Yeast as a Model System.
Ertekin E; Gencturk E; Kasim M; Ulgen KO
OMICS; 2020 Feb; 24(2):96-109. PubMed ID: 31895625
[TBL] [Abstract][Full Text] [Related]
37. Next-generation drug repurposing using human genetics and network biology.
Nabirotchkin S; Peluffo AE; Rinaudo P; Yu J; Hajj R; Cohen D
Curr Opin Pharmacol; 2020 Apr; 51():78-92. PubMed ID: 31982325
[TBL] [Abstract][Full Text] [Related]
38. Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing.
Xiang S; Lawrence PJ; Peng B; Chiang C; Kim D; Shen L; Ning X
Pac Symp Biocomput; 2024; 29():306-321. PubMed ID: 38160288
[TBL] [Abstract][Full Text] [Related]
39. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
40. Human Pathway-Based Disease Network.
Yu L; Gao L
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(4):1240-1249. PubMed ID: 29990107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
